Can Targeting Normoxemia Benefit Critically Ill Trauma Patients?

(MedPage Today) -- PHOENIX -- Targeting normoxemia in critically ill trauma patients appeared to increase supplemental oxygen-free days in a cluster randomized stepped-wedge trial that missed on statistical significance.
Through 28 days, patients...

Source: MedPage Today Neurology - January 24, 2024 Category: Neurology Source Type: news